United States - English - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - hydralazine hydrochloride (unii: fd171b778y) (hydralazine - unii:26nak24ls8), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), reserpine (unii: 8b1qwr724a) (reserpine - unii:8b1qwr724a) - tablet, coated - 25 mg - hypertension (see boxed warning). hypersensitivity to reserpine; mental depression or history of mental depression (especially with suicidal tendencies); active peptic ulcer, ulcerative colitis; patients receiving electroconvulsive therapy. hypersensitivity to hydralazine; coronary artery disease; mitral valvular rheumatic heart disease. anuria; hypersensitivity to this or other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

unichem pharmaceuticals (usa), inc. - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), bisoprolol fumarate (unii: ur59kn573l) (bisoprolol - unii:y41js2nl6u) - hydrochlorothiazide 6.25 mg - bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension. bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see warnings), second or third degree av block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

Canada - English - Health Canada

novopharm limited - reserpine - tablet - .25mg - reserpine .25mg - peripheral adrenergic inhibitors

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sandoz private limited - reserpine, dihydralazine sulfate, hydrochlorothiazide - tablets - 0,1g+10mg+10mg